You are here
Final decisions amending, or not amending, the current Poisons Standard, April 2018
Scheduling medicines and poisons
Part A - Final decisions on matters referred to an expert advisory committee (November 2017)
3. Advisory Committee on Chemicals Scheduling (ACCS #21)
Delegate's final decision
The delegate's final decision is to amend the Schedule 6 entry for alpha-cypermethrin by increasing the permitted concentration of alpha-cypermethrin from 25% to 30% in aqueous preparations as follows:
Schedule 6 - Amend Entry
- in aqueous preparations containing 30 per cent or less of alpha-cypermethrin; or
- in other preparations containing 10 per cent or less of alpha-cypermethrin,
except when included in Schedule 5.
Implementation date: 1 June 2018
As no new evidence has been received to alter the interim decision for alpha-cypermethrin, the delegate has confirmed that the final decision and reasons for the final decision are identical to the interim decision.
Public submissions on the interim decision
No public submissions were received.
The interim decision for alpha-cypermethrin was published on the TGA website on 5 February 2018 at Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017 - 3.3. Alpha-cypermethrin.
The pre-meeting scheduling proposal for alpha-cypermethrin was published on the TGA website on 6 September 2017 at Consultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, November 2017.